JPWO2021035177A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021035177A5 JPWO2021035177A5 JP2022511274A JP2022511274A JPWO2021035177A5 JP WO2021035177 A5 JPWO2021035177 A5 JP WO2021035177A5 JP 2022511274 A JP2022511274 A JP 2022511274A JP 2022511274 A JP2022511274 A JP 2022511274A JP WO2021035177 A5 JPWO2021035177 A5 JP WO2021035177A5
- Authority
- JP
- Japan
- Prior art keywords
- variant
- domain monomer
- domain
- amino acid
- substitution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (27)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962890475P | 2019-08-22 | 2019-08-22 | |
US62/890,475 | 2019-08-22 | ||
US201962897036P | 2019-09-06 | 2019-09-06 | |
US62/897,036 | 2019-09-06 | ||
US201962941405P | 2019-11-27 | 2019-11-27 | |
US62/941,405 | 2019-11-27 | ||
US201962948143P | 2019-12-13 | 2019-12-13 | |
US62/948,143 | 2019-12-13 | ||
US202062959857P | 2020-01-10 | 2020-01-10 | |
US62/959,857 | 2020-01-10 | ||
US202062966500P | 2020-01-27 | 2020-01-27 | |
US62/966,500 | 2020-01-27 | ||
US202062970491P | 2020-02-05 | 2020-02-05 | |
US62/970,491 | 2020-02-05 | ||
US202062984705P | 2020-03-03 | 2020-03-03 | |
US62/984,705 | 2020-03-03 | ||
US202062988304P | 2020-03-11 | 2020-03-11 | |
US62/988,304 | 2020-03-11 | ||
US202062988821P | 2020-03-12 | 2020-03-12 | |
US62/988,821 | 2020-03-12 | ||
US202063032488P | 2020-05-29 | 2020-05-29 | |
US202063032316P | 2020-05-29 | 2020-05-29 | |
US63/032,488 | 2020-05-29 | ||
US63/032,316 | 2020-05-29 | ||
US202063062377P | 2020-08-06 | 2020-08-06 | |
US63/062,377 | 2020-08-06 | ||
PCT/US2020/047490 WO2021035177A2 (fr) | 2019-08-22 | 2020-08-21 | Domaines fc variants et leurs utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022545106A JP2022545106A (ja) | 2022-10-25 |
JPWO2021035177A5 true JPWO2021035177A5 (fr) | 2023-08-28 |
Family
ID=74660747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022511274A Pending JP2022545106A (ja) | 2019-08-22 | 2020-08-21 | バリアントfcドメイン及びその使用 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20220175943A1 (fr) |
EP (1) | EP4017529A4 (fr) |
JP (1) | JP2022545106A (fr) |
KR (1) | KR20220066276A (fr) |
CN (1) | CN114599389A (fr) |
AU (1) | AU2020333967A1 (fr) |
CA (1) | CA3152009A1 (fr) |
MX (1) | MX2022002171A (fr) |
WO (1) | WO2021035177A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2020340881A1 (en) | 2020-04-02 | 2021-10-21 | Regeneron Pharmaceuticals, Inc. | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments |
CN116057069A (zh) | 2020-06-03 | 2023-05-02 | 瑞泽恩制药公司 | 用抗SARS-CoV-2刺突糖蛋白抗体治疗或预防SARS-CoV-2感染和COVID-19的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101802197A (zh) * | 2007-05-14 | 2010-08-11 | 比奥根艾迪克Ma公司 | 单链FC(ScFc)区、包含其的结合多肽及与其相关的方法 |
WO2011103584A2 (fr) * | 2010-02-19 | 2011-08-25 | Xencor, Inc. | Nouvelles immunoadhésines ctla4-1g |
SG194099A1 (en) * | 2011-04-15 | 2013-11-29 | Compugen Ltd | Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer |
TW201817745A (zh) * | 2011-09-30 | 2018-05-16 | 日商中外製藥股份有限公司 | 具有促進抗原清除之FcRn結合域的治療性抗原結合分子 |
WO2018128826A1 (fr) * | 2017-01-06 | 2018-07-12 | Cidara Therapeutics, Inc. | Compositions et méthodes de traitement d'infections bactériennes |
US20200148779A1 (en) * | 2017-05-25 | 2020-05-14 | Bristol-Myers Squibb Company | MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THEREWITH |
EP3665195A4 (fr) * | 2017-08-11 | 2021-05-19 | Research Development Foundation | Variants d'anticorps fc modifiés pour demi-vie sérique améliorée |
JP2021506291A (ja) * | 2017-12-19 | 2021-02-22 | ゼンコア インコーポレイテッド | 改変されたil−2 fc融合タンパク質 |
US20230079107A1 (en) * | 2019-06-13 | 2023-03-16 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of human immunodeficiency virus |
-
2020
- 2020-08-21 JP JP2022511274A patent/JP2022545106A/ja active Pending
- 2020-08-21 EP EP20854547.5A patent/EP4017529A4/fr active Pending
- 2020-08-21 WO PCT/US2020/047490 patent/WO2021035177A2/fr unknown
- 2020-08-21 CA CA3152009A patent/CA3152009A1/fr active Pending
- 2020-08-21 MX MX2022002171A patent/MX2022002171A/es unknown
- 2020-08-21 KR KR1020227009203A patent/KR20220066276A/ko unknown
- 2020-08-21 AU AU2020333967A patent/AU2020333967A1/en active Pending
- 2020-08-21 CN CN202080073726.1A patent/CN114599389A/zh active Pending
-
2022
- 2022-02-18 US US17/675,775 patent/US20220175943A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7523897B2 (ja) | 呼吸器合胞体ウイルス(rsv)ワクチン | |
JP7556848B2 (ja) | mRNA治療薬を使用したがんを治療するための方法及び組成物 | |
JP7150608B6 (ja) | 多量体コード核酸及びその使用 | |
JP2023103250A (ja) | 活性化がん遺伝子変異ペプチドをコードする免疫調節治療mRNA組成物 | |
TWI528963B (zh) | 治療或預防眼科疾病的方法 | |
JP7418419B2 (ja) | 核酸送達のための第三級アミノ脂質化カチオン性ペプチド | |
JP7170820B2 (ja) | 修飾オリゴヌクレオチド及び使用方法 | |
JP2023109824A (ja) | GalNAc誘導体 | |
JP7269968B2 (ja) | ペプチド担体上の多重オリゴヌクレオチド部分 | |
JP2017506521A5 (fr) | ||
CA3003399A1 (fr) | Polypeptides conditionnellement actifs | |
JP2013540770A5 (fr) | ||
EP2438079A2 (fr) | Compositions pour l'administration d'acides nucléiques et procédés pour les utiliser | |
CN113785054A (zh) | 包含艾杜糖醛酸2-硫酸酯酶的蛋白质分子制剂 | |
JP2022126804A5 (fr) | ||
CN107708416A (zh) | 肽组合物和使用方法 | |
JP2024040213A (ja) | 高濃縮アルファ-1プロテイナーゼインヒビターを含む組成物及びそれを得るための方法 | |
CN118159278A (zh) | 单链可变片段(scFv)修饰的脂质纳米颗粒组合物及其用途 | |
JPWO2021035177A5 (fr) | ||
JP2020507350A5 (fr) | ||
JP2001515060A (ja) | 新リポポリアミン、その調製および適用 | |
AU2021314336A1 (en) | Compositions and methods for treating viral infections | |
JPWO2020092019A5 (fr) | ||
JP2023516392A (ja) | アプタマーおよびその使用 | |
JP2017538681A5 (fr) |